ArticleNature medicine2025
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.
Abstract readPublished Erratum
In one paragraph
Article in Nature medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Integrating oncolytic adenoviruses into combination cancer therapy: Mechanisms, advances and clinical outlook.Clinical and translational medicine · 2026Review
- Redefining the Diagnostic and Therapeutic Landscape of Non-Small Cell Lung Cancer in the Era of Precision Medicine.Journal of clinical medicine · 2025Review
Corrections and comments
- Erratum for
Authors and funding
39 authors.
Farshad NassiriDivision of Neurosurgery, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0002-0797-3425
Vikas PatilPrincess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
Leeor S YefetPrincess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
Olivia SinghPrincess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0001-7321-6775
Jeff LiuPrincess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
Rachel M A DangDepartment of Human Genetics, University of California Los Angeles, Los Angeles, CA, USA.
Takafumi N YamaguchiDepartment of Human Genetics, University of California Los Angeles, Los Angeles, CA, USA.
Mariza DarasDivision of Neuro-oncology, University of California San Francisco, San Francisco, CA, USA.
Timothy F CloughesyUCLA Neuro-Oncology Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-8656-7483
Howard ColmanHuntsman Cancer Institute and Department of Neurosurgery, University of Utah, Salt Lake City, UT, USA.
Priya U KumthekarDepartment of Neurology, Division of Neuro-Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Clark C ChenDepartment of Neurosurgery, University of Minnesota, Minneapolis, MI, USA.ORCID http://orcid.org/0000-0001-9544-2570
Robert AikenRutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.
Morris D GrovesDepartment of Neurology, Texas Oncology, Austin, TX, USA.
Shirley S OngDivision of Neuro-Oncology, Department of Neurology, the Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Rohan RamakrishnaDepartment of Neurological Surgery, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA.
Michael A VogelbaumDepartment of Neuro-Oncology, Neuro-Oncology Program, Moffitt Cancer Center, Tampa, FL, USA.
Simon KhagiDivision of Medical Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Thomas KaleyDepartment of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Jason M MelearDepartment of Internal Medicine, Baylor University Medical Center, Dallas, TX, USA.
David M PeereboomThe Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH, USA.
Analiz RodriguezDepartment of Neurosurgery, University of Arkansas for Medical Sciences, Little Rock, AK, USA.
Maxim YankelevichDepartment of Pediatrics, University of Michigan, Ann Arbor Beaumont Children's Hospital, Royal Oak, MI, USA.
Suresh G NairLehigh Valley Topper Cancer Institute, Allentown, PA, USA.
Vinay K PuduvalliDepartment of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Kenneth AldapeLaboratory of Pathology, National Cancer Institute, Bethesda, MD, USA.ORCID http://orcid.org/0000-0001-5119-7550
Andrew GaoDepartment of Laboratory Medicine and Pathobiology, University Health Network, Toronto, Ontario, Canada.
Álvaro López-JaneiroDepartment of Pathology, Clínica Universidad de Navarra, Pamplona, Spain.
Carlos E de AndreaDepartment of Pathology, Clínica Universidad de Navarra, Pamplona, Spain.
Marta M AlonsoNavarra Institute for Health Research (IdISNA), Pamplona, Spain.ORCID http://orcid.org/0000-0002-7520-7351
Paul BoutrosDepartment of Human Genetics, University of California Los Angeles, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0003-0553-7520
Joan RobbinsDNATrix Inc., Carlsbad, CA, USA.
Warren P MasonPrincess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
Adam M SonabendDepartment of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Roger StuppDepartment of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-5483-3118
Juan FueyoDepartment of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Candelaria Gomez-ManzanoDepartment of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-1259-2133
Frederick F LangDepartment of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0003-3747-873X
Gelareh ZadehDivision of Neurosurgery, University of Toronto, Toronto, Ontario, Canada. gelareh.zadeh@uhn.ca.ORCID http://orcid.org/0000-0002-6637-4502
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.